Ranbaxy March qtr PAT seen at Rs 267cr: KRChoksey

KRChoksey has come out with its earning estimates on pharma sector for the quarter ended March 2011. According to the research firm, Ranbaxy Laboratories March quarter sales are expected to go down by 17% at Rs 2,310 crore, year-on-year, (YoY) basis.

April 06, 2011 / 14:27 IST

KRChoksey has come out with its earning estimates on pharma sector for the quarter ended March 2011. According to the research firm, Ranbaxy Laboratories March quarter sales are expected to go down by 17% at Rs 2,310 crore, year-on-year, (YoY) basis.

The company's net profit is expected to go down by 72% at Rs 267 crore on YoY basis.

first published: Apr 6, 2011 02:25 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Ranbaxy March qtr PAT seen at Rs 267cr: KRChoksey

KRChoksey has come out with its earning estimates on pharma sector for the quarter ended March 2011. According to the research firm, Ranbaxy Laboratories March quarter sales are expected to go down by 17% at Rs 2,310 crore, year-on-year, (YoY) basis.

RL